Retinal Health
Pipeline

About our Retinal Health efforts

The ambition to prevent vision loss in people at risk, and preserve or restore vision in those with retinal diseases, is at the core of our R&D activities. Our extensive knowledge and insights from other therapeutic areas enable us to tackle the multifactorial pathophysiology of retinal diseases. Areas of focus include wet age-related macular degeneration, diabetic retinopathy and geographic atrophy.

Read more about BI 764524: Sema3A antibody

Retinal Health

Diabetic retinopathy

Sema3A antibody

BI 764524

Read more about C3-binding polypeptide

Retinal Health

C3-binding polypeptide

Read more about Phospholipid modulator

Retinal Health

Phospholipid modulator

Read more about Vascular modulator

Retinal Health

Vascular modulator